Why the study?
Does distal splenorenal shunt reduce spontaneous encephalopathy and improve survival compared to end-to-side portacaval shunt in patients with variceal bleeding?
Does distal splenorenal shunt reduce spontaneous encephalopathy and improve survival compared to end-to-side portacaval shunt in patients with variceal bleeding?
Distal splenorenal shunts reduce the incidence and severity of spontaneous encephalopathy compared to end-to-side portacaval shunts, despite higher initial operative demands and slightly higher postoperative mortality, with similar long-term survival.
Answers are grounded in this paper and cite their sources.
Selective shunts lower encephalopathy risk without survival difference; supports preference over nonselective shunts for variceal bleeding.
We electively compared the distal splenorenal (selective) shunt with the end-to-side portacaval shunt in 80 prospectively randomized patients with variceal bleeding. Selective shunts required more operative time (3.9 vs. 2.8 h) and blood replacement (4.6 vs. 2.5 U) and postoperative mortality was slightly higher (5 of 38 selective vs. 0 of 40 portacaval). Postoperative complication rates were similar. After 65-mo mean follow-up, both shunts have protected well against late gastrointestinal bleeding (5 selective, 4 portacaval episodes). However, after selective shunts, spontaneous encephalopathy occurred less often (23% vs. 40% of patients), was severe in fewer patients (12% vs. 33%), and precipitated fewer hospital admissions (6 admissions in 4 selective patients vs. 26 admissions in 13 portacaval patients). Furthermore, selective shunt patients remained longer without functional disability (83% vs. 70% of postoperative patient months). Long-term survival was not significantly different in the two groups (5-yr survival: selective 51%, portacaval 56%).
No takes yet. Share an insight, caveat, or question.
Langer et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: